November 2016 – Pixium Vision

ARTIFICIAL VISION : Pixium Vision: First Clinical Results and Innovative Developments

Pixium Vision and its partners are developing two VRS solutions for blind patients: an epi-retinal and a sub-retinal approach. This chapter describes the specificities of the epi-retinal IRIS^®VRS that has obtained the European CE mark cerfication, and also discuss the associatedinnovations developed at the Vision Institute for future VRS models.

Pixium Vision and Silamir, honoured at Quai d’Orsay, during the Award Ceremony of Janus 2016 from French Institute of Design

Read the PDF »

admin2019-09-11T17:32:32+02:00November 22nd, 2016|Press Releases|

Functional Vision vs Visual Function – Working Towards Integrating Patient Perspective in Retinal Res

As the global patient-led umbrella group representing the voice of people living with Retinal Degenerative Diseases, Retina International (RI) and its members believe that the outcomes of clinical trials and therapy development would benefit from better integrating what is important to the patient.

Pixium Vision announces the first successful implantation and activation of IRIS® II, 150 electrode bionic vision system, in the UK

Read the PDF »

admin2019-09-11T17:32:53+02:00November 7th, 2016|Press Releases|